← Back to Screener
NewAmsterdam Pharma Company N.V. Warrant (NAMSW)
Price$24.89
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-11.89%
Price vs S&P 500 (4W)12.15%
VGM Score66.60
All Metrics
Price vs S&P 500 (YTD)-0.27%
10-Day Avg Trading Volume0.00M
3-Month Avg Trading Volume0.00M
52-Week Price Return243.61%
52-Week High$30.45
26-Week Price Return1.99%
13-Week Price Return25.29%
3-Month Return Std Dev113.03%
Price vs S&P 500 (52W)219.76%
Year-to-Date Return8.24%
5-Day Price Return-16.99%
Month-to-Date Return17.26%
Price vs S&P 500 (13W)16.42%
Beta6.76x
52-Week Low$7.16
mGradeB
vgmGradeB
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NAMSWNewAmsterdam Pharma Company N.V. Warrant | — | — | B | $24.89 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
NewAmsterdam Pharma is a late-stage biopharmaceutical company developing therapies for cardio-metabolic diseases. Its lead product, obicetrapib, is an oral CETP inhibitor designed to overcome the efficacy and tolerability limitations of current LDL cholesterol-lowering treatments in patients with inadequate response or poor tolerance to existing therapies.